A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test

Terminated

• Conditions: Neoplasm Metastasis
• Interventions: Device: Pathwork® Tissue of Origin Test

• Registration Number: NCT01649453
• Lead Sponsor: Cedar Associates LLC

Brief Summary

The study prospectively assesses the change in cancer-specific clinical decisions and outcomes before and after physicians received results from the Pathwork® Tissue of Origin (TOO) Test for patients whose primary site of cancer origin is uncertain.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-05
• Study First Submitted: 2012-07-23
• Study First Submitted QC: 2012-07-24
• Study First Posted: 2012-07-25
• Primary Completion: 2013-01
• Study Completion: 2013-02
• Status Verified: 2013-03
• Last Update Submitted: 2013-03-04
• Last Update Posted: 2013-03-06

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

• their physician ordered or intends to order a Pathwork® TOO Test between May 2012 and December 2013
• the patient is ≥ 18 years of age
• the patient has given informed consent (online or verbal)
• the patient is able to understand English.

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Cancer of uncertain primary	Pathwork® Tissue of Origin Test	-

Primary Outcome Measures

Name	Time	Method
Survival	2 years

Trial Locations

Locations (1)

Cedar Associates LLC; 🇺🇸 Menlo Park, California, United States